KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Other Non-Current Liabilities (2020 - 2025)

AbCellera Biologics' Other Non-Current Liabilities history spans 6 years, with the latest figure at $1.4 million for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities fell 9.06% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Sep 2025, down 9.06%, and an annual FY2024 reading of $7.2 million, up 21.39% over the prior year.
  • Other Non-Current Liabilities for Q3 2025 was $1.4 million at AbCellera Biologics, down from $1.6 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $44.9 million in Q3 2021, with the low at $931000.0 in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $8.9 million, with a median of $4.4 million recorded in 2024.
  • Year-over-year, Other Non-Current Liabilities surged 292.28% in 2021 and then crashed 91.4% in 2022.
  • Tracing ABCL's Other Non-Current Liabilities over 5 years: stood at $35.9 million in 2021, then crashed by 91.4% to $3.1 million in 2022, then skyrocketed by 91.38% to $5.9 million in 2023, then increased by 21.39% to $7.2 million in 2024, then plummeted by 80.67% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Other Non-Current Liabilities are $1.4 million (Q3 2025), $1.6 million (Q2 2025), and $1.6 million (Q1 2025).